Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
PAX7 expression defines germline stem cells in the adult testis
Gina M. Aloisio, … , F. Kent Hamra, Diego H. Castrillon
Gina M. Aloisio, … , F. Kent Hamra, Diego H. Castrillon
Published August 18, 2014
Citation Information: J Clin Invest. 2014;124(9):3929-3944. https://doi.org/10.1172/JCI75943.
View: Text | PDF
Research Article

PAX7 expression defines germline stem cells in the adult testis

  • Text
  • PDF
Abstract

Spermatogenesis is a complex, multistep process that maintains male fertility and is sustained by rare germline stem cells. Spermatogenic progression begins with spermatogonia, populations of which express distinct markers. The identity of the spermatogonial stem cell population in the undisturbed testis is controversial due to a lack of reliable and specific markers. Here we identified the transcription factor PAX7 as a specific marker of a rare subpopulation of Asingle spermatogonia in mice. PAX7+ cells were present in the testis at birth. Compared with the adult testis, PAX7+ cells constituted a much higher percentage of neonatal germ cells. Lineage tracing in healthy adult mice revealed that PAX7+ spermatogonia self-maintained and produced expanding clones that gave rise to mature spermatozoa. Interestingly, in mice subjected to chemotherapy and radiotherapy, both of which damage the vast majority of germ cells and can result in sterility, PAX7+ spermatogonia selectively survived, and their subsequent expansion contributed to the recovery of spermatogenesis. Finally, PAX7+ spermatogonia were present in the testes of a diverse set of mammals. Our data indicate that the PAX7+ subset of Asingle spermatogonia functions as robust testis stem cells that maintain fertility in normal spermatogenesis in healthy mice and mediate recovery after severe germline injury, such as occurs after cancer therapy.

Authors

Gina M. Aloisio, Yuji Nakada, Hatice D. Saatcioglu, Christopher G. Peña, Michael D. Baker, Edward D. Tarnawa, Jishnu Mukherjee, Hema Manjunath, Abhijit Bugde, Anita L. Sengupta, James F. Amatruda, Ileana Cuevas, F. Kent Hamra, Diego H. Castrillon

×

Figure 12

Models of stemness in mouse spermatogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Models of stemness in mouse spermatogenesis.
Spermatogonial subsets prop...
Spermatogonial subsets proposed as the bona fide stem cells are shown above each of the 3 models. In the classic Asingle model (As), Asingle spermatogonia are homogeneous and share stem cell identity (green), having the capacity for self-maintenance (circular arrows; refs. 3, 4, 66). More recently, models have been proposed arguing for greater plasticity among undifferentiated (Asingle→Aal16) spermatogonia, with chain fragmentation representing one possible mechanism by which stemness is maintained or regenerated (5). Although fragmentation has been shown to occur in vivo, its contributions to stem cell maintenance under normal conditions or after chemotherapy/radiation have not been formally established. Our findings that only a subset of Asingle spermatogonia expressed PAX7 and that these spermatogonia functioned as stem cells suggests a new Asingle subset model, whereby PAX7+ spermatogonia are self-maintaining and may sit atop the hierarchy of spermatogenic differentiation. That Asingle spermatogonia were heterogeneous and that only a subset functioned as stem cells was also suggested by previous studies (10, 67). If so, then this would suggest that some subset of Asingle spermatogonia represent transit-amplifying (TA) intermediates. The number of such transit-amplifying steps between PAX7+ Asingle and Apair spermatogonia is unknown. It will be interesting to determine whether ID4 and ERBB3, expressed in Asingle spermatogonia, are expressed in overlapping or nonoverlapping subsets of spermatogonia relative to PAX7 (9, 49, 50). Other models are possible, such as ones combining different aspects of these models (i.e., fragmentation with the presence of PAX7+ spermatogonia, if fragmentation is confirmed as a functionally significant biological process).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts